ID

37737

Description

Phase 2 Trial Of CP-751,871 And Docetaxel In Advanced Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00678626

Link

https://clinicaltrials.gov/show/NCT00678626

Keywords

  1. 8/20/19 8/20/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

August 20, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Breast Cancer NCT00678626

Eligibility Breast Cancer NCT00678626

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically confirmed diagnosis with evidence of either metastatic disease (stage iv) of locally recurrent disease not amenable to curative resection or radiation therapy (stage iiib).
Description

Neoplasm Metastasis TNM Breast tumor staging | Recurrent disease Locally TNM Breast tumor staging | Excision Curative Unsuccessful | Therapeutic radiology procedure Unsuccessful

Data type

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C0474926
UMLS CUI [2,1]
C0277556
UMLS CUI [2,2]
C1517927
UMLS CUI [2,3]
C0474926
UMLS CUI [3,1]
C0728940
UMLS CUI [3,2]
C1276305
UMLS CUI [3,3]
C1272705
UMLS CUI [4,1]
C1522449
UMLS CUI [4,2]
C1272705
her-2negative breast cancer or unknown her-2 status.
Description

Breast Carcinoma HER2 Negative | HER2 Status Unknown

Data type

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C2348908
UMLS CUI [2]
C2348910
at least 1 measurable lesion as defined by recist.
Description

Measurable Disease Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1265611
ecog status 0-1
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
adequate bone marrow, hepatic and renal function.
Description

Bone Marrow function | Liver function | Renal function

Data type

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0232804
left ventricular ejection fraction of greater than or equal to 50%.
Description

Left ventricular ejection fraction

Data type

boolean

Alias
UMLS CUI [1]
C0428772
willingness to discontinue hormonal therapy.
Description

Hormone Therapy Discontinue Willing

Data type

boolean

Alias
UMLS CUI [1,1]
C0279025
UMLS CUI [1,2]
C1444662
UMLS CUI [1,3]
C0600109
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
any previous chemotherapy for advanced disease.
Description

Prior Chemotherapy Advanced disease

Data type

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C0679246
prior exposure to taxanes as (neo) adjuvant treatment less than 12 months prior to randomization.
Description

Exposure to Taxanes Adjuvant therapy | Exposure to Taxanes Neoadjuvant Therapy

Data type

boolean

Alias
UMLS CUI [1,1]
C0332157
UMLS CUI [1,2]
C0796419
UMLS CUI [1,3]
C0677850
UMLS CUI [2,1]
C0332157
UMLS CUI [2,2]
C0796419
UMLS CUI [2,3]
C0600558
symptomatic brain metastases.
Description

Metastatic malignant neoplasm to brain Symptomatic

Data type

boolean

Alias
UMLS CUI [1,1]
C0220650
UMLS CUI [1,2]
C0231220
prior anti-igf-1r based investigational therapy.
Description

IGF1R inhibitors Investigational Therapy

Data type

boolean

Alias
UMLS CUI [1,1]
C4044495
UMLS CUI [1,2]
C0243077
UMLS CUI [1,3]
C0949266
peripheral neuropathy greater than grade 2.
Description

Peripheral Neuropathy CTCAE Grades

Data type

boolean

Alias
UMLS CUI [1,1]
C0031117
UMLS CUI [1,2]
C1516728

Similar models

Eligibility Breast Cancer NCT00678626

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Neoplasm Metastasis TNM Breast tumor staging | Recurrent disease Locally TNM Breast tumor staging | Excision Curative Unsuccessful | Therapeutic radiology procedure Unsuccessful
Item
histologically or cytologically confirmed diagnosis with evidence of either metastatic disease (stage iv) of locally recurrent disease not amenable to curative resection or radiation therapy (stage iiib).
boolean
C0027627 (UMLS CUI [1,1])
C0474926 (UMLS CUI [1,2])
C0277556 (UMLS CUI [2,1])
C1517927 (UMLS CUI [2,2])
C0474926 (UMLS CUI [2,3])
C0728940 (UMLS CUI [3,1])
C1276305 (UMLS CUI [3,2])
C1272705 (UMLS CUI [3,3])
C1522449 (UMLS CUI [4,1])
C1272705 (UMLS CUI [4,2])
Breast Carcinoma HER2 Negative | HER2 Status Unknown
Item
her-2negative breast cancer or unknown her-2 status.
boolean
C0678222 (UMLS CUI [1,1])
C2348908 (UMLS CUI [1,2])
C2348910 (UMLS CUI [2])
Measurable Disease Quantity
Item
at least 1 measurable lesion as defined by recist.
boolean
C1513041 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
ECOG performance status
Item
ecog status 0-1
boolean
C1520224 (UMLS CUI [1])
Bone Marrow function | Liver function | Renal function
Item
adequate bone marrow, hepatic and renal function.
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Left ventricular ejection fraction
Item
left ventricular ejection fraction of greater than or equal to 50%.
boolean
C0428772 (UMLS CUI [1])
Hormone Therapy Discontinue Willing
Item
willingness to discontinue hormonal therapy.
boolean
C0279025 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C0600109 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Prior Chemotherapy Advanced disease
Item
any previous chemotherapy for advanced disease.
boolean
C1514457 (UMLS CUI [1,1])
C0679246 (UMLS CUI [1,2])
Exposure to Taxanes Adjuvant therapy | Exposure to Taxanes Neoadjuvant Therapy
Item
prior exposure to taxanes as (neo) adjuvant treatment less than 12 months prior to randomization.
boolean
C0332157 (UMLS CUI [1,1])
C0796419 (UMLS CUI [1,2])
C0677850 (UMLS CUI [1,3])
C0332157 (UMLS CUI [2,1])
C0796419 (UMLS CUI [2,2])
C0600558 (UMLS CUI [2,3])
Metastatic malignant neoplasm to brain Symptomatic
Item
symptomatic brain metastases.
boolean
C0220650 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
IGF1R inhibitors Investigational Therapy
Item
prior anti-igf-1r based investigational therapy.
boolean
C4044495 (UMLS CUI [1,1])
C0243077 (UMLS CUI [1,2])
C0949266 (UMLS CUI [1,3])
Peripheral Neuropathy CTCAE Grades
Item
peripheral neuropathy greater than grade 2.
boolean
C0031117 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial